Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow Reinvestment Rate
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Reinvestment Rate of 1.47x as of September 2025, reinvesting CN¥414.56 Million (capex CN¥414.56 Million ) from operating cash flow of CN¥282.81 Million. Explore 600521 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Also explore 600521 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Zhejiang Huahai Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.05 Billion | CN¥1.23 Billion | CN¥1.97 Billion | ▲ +88.5% |
| 2024 | 0.89x | CN¥1.93 Billion | CN¥2.17 Billion | CN¥1.85 Billion | ▼ -38.9% |
| 2023 | 1.45x | CN¥3.22 Billion | CN¥2.22 Billion | CN¥1.59 Billion | ▼ -62.1% |
| 2022 | 3.82x | CN¥4.75 Billion | CN¥1.24 Billion | CN¥2.32 Billion | ▲ +43.9% |
| 2021 | 2.66x | CN¥2.49 Billion | CN¥938.43 Million | CN¥2.43 Billion | ▲ +197.2% |
| 2020 | 0.89x | CN¥1.39 Billion | CN¥1.56 Billion | CN¥1.28 Billion | ▲ +95.6% |
| 2019 | 0.46x | CN¥801.28 Million | CN¥1.75 Billion | CN¥794.31 Million | ▼ -97.5% |
| 2018 | 18.56x | CN¥1.26 Billion | CN¥67.90 Million | CN¥1.12 Billion | ▲ +787.1% |
| 2017 | 2.09x | CN¥1.14 Billion | CN¥546.24 Million | CN¥794.54 Million | ▲ +21.5% |
| 2016 | 1.72x | CN¥746.05 Million | CN¥433.10 Million | CN¥732.88 Million | ▼ -52.3% |
| 2015 | 3.61x | CN¥705.17 Million | CN¥195.31 Million | CN¥524.28 Million | ▲ +171.5% |
| 2014 | 1.33x | CN¥437.06 Million | CN¥328.61 Million | CN¥437.06 Million | ▲ +39.9% |
| 2013 | 0.95x | CN¥466.24 Million | CN¥490.29 Million | CN¥466.24 Million | ▼ -48.2% |
| 2012 | 1.84x | CN¥447.81 Million | CN¥243.83 Million | CN¥447.81 Million | ▲ +4.8% |
| 2011 | 1.75x | CN¥346.06 Million | CN¥197.51 Million | CN¥346.06 Million | ▲ +92.6% |
| 2010 | 0.91x | CN¥272.44 Million | CN¥299.47 Million | CN¥272.44 Million | ▲ +120.8% |
| 2009 | 0.41x | CN¥130.81 Million | CN¥317.44 Million | CN¥130.81 Million | ▼ -75.0% |
| 2008 | 1.65x | CN¥138.89 Million | CN¥84.20 Million | CN¥138.89 Million | ▲ +86.8% |
| 2007 | 0.88x | CN¥120.54 Million | CN¥136.52 Million | CN¥120.54 Million | ▼ -50.5% |
| 2006 | 1.78x | CN¥138.27 Million | CN¥77.54 Million | CN¥138.27 Million | ▼ -61.9% |
| 2005 | 4.67x | CN¥249.14 Million | CN¥53.30 Million | CN¥249.14 Million | ▲ +540.6% |
| 2004 | 0.73x | CN¥119.47 Million | CN¥163.73 Million | CN¥119.47 Million | ▼ -26.6% |
| 2003 | 0.99x | CN¥47.13 Million | CN¥47.41 Million | CN¥47.13 Million | ▲ +54.1% |
| 2002 | 0.65x | CN¥48.60 Million | CN¥75.34 Million | CN¥48.60 Million | ▼ -33.1% |
| 2001 | 0.96x | CN¥36.14 Million | CN¥37.51 Million | CN¥36.14 Million | — |